Travere Therapeutics TVTX paid The Health Equity Strategies Group $22.5K for lobbying in Q1 2023 · Health Issues, Medical and 2 more issues

Trade details

Type: Lobbying report
Amount: $22,500
Quarter: Q1 2023
Stock: Travere Therapeutics TVTX
Client: Travere Therapeutics
Reported: 23/04/25

Up 0.0% from last quarter

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Travere Therapeutics's other lobbying reports

Travere Therapeutics
LobbyingTravere Therapeutics
Lobbying
Travere Therapeutics
TVTX
$16K
$16K
Reported 08/04
for Q2
Travere Therapeutics
LobbyingTravere Therapeutics
Lobbying
Travere Therapeutics
TVTX
$70K
$70K
Reported 07/20
for Q2
Travere Therapeutics
LobbyingTravere Therapeutics
Lobbying
Travere Therapeutics
TVTX
$140K
$140K
Reported 07/20
for Q2
Travere Therapeutics
LobbyingTravere Therapeutics
Lobbying
Travere Therapeutics
TVTX
$16K
$16K
Reported 05/19
for Q1
Travere Therapeutics
LobbyingTravere Therapeutics
Lobbying
Travere Therapeutics
TVTX
$80K
$80K
Reported 04/20
for Q1

Travere Therapeutics TVTX paid The Health Equity Strategies Group $22.5K for lobbying in Q1 2023 · Health Issues, Medical and 2 more issues | Whalegun